Jose Manuel Entenza

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


104 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
Temperate Prophages Increase Bacterial Adhesin Expression and Virulence in an Experimental Model of Endocarditis Due to Staphylococcus aureus From the CC398 Lineage.
Laumay F., Corvaglia A.R., Diene S.M., Girard M., Oechslin F., van der Mee-Marquet N., Entenza J.M., François P., 2019. Frontiers in microbiology, 10 p. 742. Peer-reviewed.
 
Solar photo-Fenton disinfection of 11 antibiotic-resistant bacteria (ARB) and elimination of representative AR genes. Evidence that antibiotic resistance does not imply resistance to oxidative treatment.
Giannakis S., Le T.M., Entenza J.M., Pulgarin C., 2018/10/15. Water research, 143 pp. 334-345. Peer-reviewed.
 
Assessment of the Dual Role of Clumping Factor A in S. Aureus Adhesion to Endothelium in Absence and Presence of Plasma.
Claes J., Ditkowski B., Liesenborghs L., Veloso T.R., Entenza J.M., Moreillon P., Vanassche T., Verhamme P., Hoylaerts M.F., Heying R., 2018/07. Thrombosis and haemostasis, 118 (7) pp. 1230-1241. Peer-reviewed.
In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria.
Larpin Y., Oechslin F., Moreillon P., Resch G., Entenza J.M., Mancini S., 2018. PloS one, 13 (2) pp. e0192507. Peer-reviewed.
 
Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations.
Mancini S., Oechslin F., Menzi C., Que Y.A., Claes J., Heying R., Veloso T.R., Vanassche T., Missiakas D., Schneewind O. et al., 2018. Virulence, 9 (1) pp. 1615-1624. Peer-reviewed.
 
Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall.
Claes J., Liesenborghs L., Peetermans M., Veloso T.R., Missiakas D., Schneewind O., Mancini S., Entenza J.M., Hoylaerts M.F., Heying R. et al., 2017/05. Journal of thrombosis and haemostasis, 15 (5) pp. 1009-1019. Peer-reviewed.
Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
Oechslin F., Piccardi P., Mancini S., Gabard J., Moreillon P., Entenza J.M., Resch G., Que Y.A., 2017/03/01. The Journal of infectious diseases, 215 (5) pp. 703-712. Peer-reviewed.
 
Fungicidal activity of copper-sputtered flexible surfaces under dark and actinic light against azole-resistant Candida albicans and Candida glabrata.
Ballo MKS, Rtimi S., Kiwi J., Pulgarin C., Entenza J.M., Bizzini A., 2017. Journal of Photochemistry and Photobiology. B, Biology, 174 pp. 229-234. Peer-reviewed.
Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.
Mancini S., Menzi C., Oechslin F., Moreillon P., Entenza J.M., 2016/12. Infection and immunity, 84 (12) pp. 3557-3563. Peer-reviewed.
 
Bactericidal activity and mechanism of action of copper-sputtered flexible surfaces against multidrug-resistant pathogens.
Ballo M.K., Rtimi S., Mancini S., Kiwi J., Pulgarin C., Entenza J.M., Bizzini A., 2016. Applied Microbiology and Biotechnology, 100 (13) pp. 5945-5953. Peer-reviewed.
Comparative Genomics Analysis of Streptococcus tigurinus Strains Identifies Genetic Elements Specifically and Uniquely Present in Highly Virulent Strains.
Diene S.M., François P., Zbinden A., Entenza J.M., Resch G., 2016. PloS one, 11 (8) pp. e0160554. Peer-reviewed.
 
Development of Potent and Selective S. aureus Sortase A Inhibitors Based on Peptide Macrocycles.
Rentero Rebollo I., McCallin S., Bertoldo D., Entenza J.M., Moreillon P., Heinis C., 2016. ACS Medicinal Chemistry Letters, 7 (6) pp. 606-611. Peer-reviewed.
 
In vitro and in vivo effectiveness of an innovative silver-copper nanoparticle coating of catheters to prevent methicillin-resistant Staphylococcus aureus infection
Ballo Myriam K.S., Rtimi Sami, Pulgarin César, Hopf Nancy, Berthet Aurélie, Kiwi John, Moreillon Philippe, Entenza José M., Bizzini Alain, 2016. Antimicrobial Agents and Chemotherapy, 60 (9) pp. 5349-5356. Peer-reviewed.
Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.
Veloso T.R., Oechslin F., Que Y.A., Moreillon P., Entenza J.M., Mancini S., 2015. Pathogens and Disease, 73 (8) pp. ftv060.
 
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
Del Río A., García-de-la-Mària C., Entenza J.M., Gasch O., Armero Y., Soy D., Mestres C.A., Pericás J.M., Falces C., Ninot S. et al., 2015. Antimicrobial Agents and Chemotherapy, 60 (1) pp. 478-486.
 
In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.
Mancini S., Laurent F., Veloso T.R., Giddey M., Vouillamoz J., Vandenesch F., Moreillon P., Entenza J.M., 2015. Antimicrobial Agents and Chemotherapy, 59 (4) pp. 2435-2438.
Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents : a role for long-term prevention of infective endocarditis in humans?
Veloso T.R., Que Y.A., Chaouch A., Giddey M., Vouillamoz J., Rousson V., Moreillon P., Entenza J.M., 2015. Journal of Infectious Diseases, 211 (1) pp. 72-79. Peer-reviewed.
Reply to Eisen and McBryde.
Veloso T.R., Que Y.A., Moreillon P., Entenza J.M., 2015. Journal of Infectious Diseases, 212 (4) pp. 674-675. Peer-reviewed.
 
Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso T.R., Mancini S., Giddey M., Vouillamoz J., Que Y.A., Moreillon P., Entenza J.M., 2015. Vaccine, 33 (30) pp. 3512-3517. Peer-reviewed.
 
Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci
Entenza J.M., Giddey M., Vouillamoz J., Moreillon P., Mancini S., 2014. Journal of Global Antimicrobial Resistance, 2 (4) pp. 306-308. Peer-reviewed.
 
Rapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry.
Entenza J.M., Bétrisey B., Manuel O., Giddey M., Sakwinska O., Laurent F., Bizzini A., 2014. Journal of Clinical Microbiology, 52 (1) pp. 180-186.
Intravenous streptomycin dosing regimen in a patient undergoing hemodialysis: Plasma level monitoring and pharmacokinetic simulation
Chtioui H., Zbinden D., Manuel O., Entenza J., Decosterd L.A., Buclin T., 2013/08. pp. e106 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
 
Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.
Vouillamoz J., Entenza J.M., Giddey M., Fischetti V.A., Moreillon P., Resch G., 2013. International Journal of Antimicrobial Agents, 42 (5) pp. 416-421.
 
Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis.
Veloso T.R., Zbinden A., Andreoni F., Giddey M., Vouillamoz J., Moreillon P., Zinkernagel A.S., Entenza J.M., 2013. International Journal of Medical Microbiology, 303 (8) pp. 498-504. Peer-reviewed.
 
Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.
Veloso T.R., Chaouch A., Roger T., Giddey M., Vouillamoz J., Majcherczyk P., Que Y.A., Rousson V., Moreillon P., Entenza J.M., 2013. Infection and Immunity, 81 (3) pp. 697-703. Peer-reviewed.
Daptomycin for highly resistant Enterococcus faecium infection.
Rosin C., Bernsmeier C., Entenza J.M., Moreillon P., Frei R., Weisser M., Flückiger U., 2012/06/26. Swiss medical weekly, 142 pp. w13603. Peer-reviewed.
 
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró J.M., Entenza J.M., Del Río A., Velasco M., Castañeda X., Garcia de la Mària C., Giddey M., Armero Y., Pericàs J.M., Cervera C. et al., 2012. Antimicrobial Agents and Chemotherapy, 56 (8) pp. 4511-4515. Peer-reviewed.
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
Moreillon P., Bizzini A., Giddey M., Vouillamoz J., Entenza J.M., 2012. Journal of Antimicrobial Chemotherapy, 67 (3) pp. 652-660.
 
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Pea F., Cojutti P., Petrosillo N., Furlanut M., Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Antimicrobial Agents and Chemotherapy, 55 (9) pp. 4496; author reply 4496-4496; author reply 4497.
 
Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Antimicrobial Agents and Chemotherapy, 55 (1) pp. 385-387. Peer-reviewed.
 
In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Majcherczyk P., Moreillon P., 2011. Antimicrobial Agents and Chemotherapy, 55 (9) pp. 3977-3984.
 
Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.
Veloso T.R., Amiguet M., Rousson V., Giddey M., Vouillamoz J., Moreillon P., Entenza J.M., 2011. Infection and Immunity, 79 (5) pp. 2006-2011.
Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis.
Danne C., Entenza J.M., Mallet A., Briandet R., Débarbouillé M., Nato F., Glaser P., Jouvion G., Moreillon P., Trieu-Cuot P. et al., 2011. Journal of Infectious Diseases, 204 (12) pp. 1960-1970.
 
Role of MyD88 and Toll-like receptors 2 and 4 in the sensing of Parachlamydia acanthamoebae.
Roger T., Casson N., Croxatto A., Entenza J.M., Pusztaszeri M., Akira S., Reymond M.K., Le Roy D., Calandra T., Greub G., 2010/12. Infection and immunity, 78 (12) pp. 5195-5201. Peer-reviewed.
 
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
Bizzini A., Entenza J.M., Michielin O., Arnold I., Erni B., Moreillon P., 2010. Antimicrobial Agents and Chemotherapy, 54 (1) pp. 259-266.
 
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
Entenza J.M., Giddey M., Vouillamoz J., Moreillon P., 2010. International Journal of Antimicrobial Agents, 35 (5) pp. 451-456.
 
Methicillin-resistant Staphylococcus aureus with intermediate susceptibility to vancomycin: are strict additional contact measures sufficient?
Nahimana Tessemo I., Bellini C., Entenza J., Zanetti G., Blanc D., 2010. pp. S294 dans 20th European Congress of Clinical Microbiology and Infectious (ECCMID), Clinical Microgiology and Infection. Peer-reviewed.
 
Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus.
Ythier M., Entenza J.M., Bille J., Vandenesch F., Bes M., Moreillon P., Sakwinska O., 2010. Infection and Immunity, 78 (4) pp. 1711-1716.
 
Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.
Entenza J.M., Haldimann A., Giddey M., Lociuro S., Hawser S., Moreillon P., 2009. Antimicrobial Agents and Chemotherapy, 53 (9) pp. 3635-3641.
MsrR contributes to cell surface characteristics and virulence in Staphylococcus aureus.
Hübscher J., McCallum N., Sifri C.D., Majcherczyk P.A., Entenza J.M., Heusser R., Berger-Bächi B., Stutzmann Meier P., 2009. FEMS Microbiology Letters, 295 (2) pp. 251-260. Peer-reviewed.
 
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.
Entenza J.M., Moreillon P., 2009. International Journal of Antimicrobial Agents, 34 (1) pp. 8.e1-8.e9.
 
Tissue microarray and immunohistochemistry as tools for evaluation of antibodies against Chlamydia-like bacteria.
Borel N., Casson N., Entenza J.M., Kaiser C., Pospischil A., Greub G., 2009. Journal of Medical Microbiology, 58 (Pt 7) pp. 863-866. Peer-reviewed.
 
Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project
Vankerckhoven V., Huys G., Vancanneyt M., Vael C., Klare I., Romond M.B., Entenza J.M., Moreillon P., Wind R.D., Knol J. et al., 2008. Trends in Food Science and Technology, 19 (2) pp. 102-114. Peer-reviewed.
 
Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis.
Majcherczyk P.A., Barblan J.L., Moreillon P., Entenza J.M., 2008. Microbial pathogenesis, 45 (5-6) pp. 408-414. Peer-reviewed.
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2008. Journal of Antimicrobial Chemotherapy, 61 (2) pp. 371-374.
 
Murine model of pneumonia caused by Parachlamydia acanthamoebae
Casson N., Entenza J.M., Borel N., Pospischil A., Greub G., 2008. Microbial Pathogenesis, 45 (2) pp. 92-97. Peer-reviewed.
 
The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis.
Piroth L., Que Y.A., Widmer E., Panchaud A., Piu S., Entenza J.M., Moreillon P., 2008. Infection and Immunity, 76 (8) pp. 3824-3831.
 
Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii.
Bizzini A., Majcherczyk P., Beggah-Möller S., Soldo B., Entenza J.M., Gaillard M., Moreillon P., Lazarevic V., 2007. Microbiology, 153 (Pt 2) pp. 490-498.
 
Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis.
Vankerckhoven V., Moreillon P., Piu S., Giddey M., Huys G., Vancanneyt M., Goossens H., Entenza J.M., 2007. Journal of Medical Microbiology, 56 (8) pp. 1017-1024.
Loss of penicillin tolerance by inactivating the carbon catabolite repression determinant CcpA in Streptococcus gordonii.
Bizzini A., Entenza J.M., Moreillon P., 2007. Journal of Antimicrobial Chemotherapy, 59 (4) pp. 607-615.
 
Serological cross-reactivity between different Chlamydia-like organisms.
Casson N., Entenza J.M., Greub G., 2007. Journal of Clinical Microbiology, 45 (1) pp. 234-236.
 
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
Moreillon P., Wilson W.R., Leclercq R., Entenza J.M., 2007. Antimicrobial Agents and Chemotherapy, 51 (5) pp. 1661-1665.
 
Adherence of Abiotrophia defectiva and Granulicatella species to fibronectin: is there a link with endovascular infections?
Senn L., Entenza J.M., Prod'hom G., 2006. FEMS Immunology and Medical Microbiology, 48 (2) pp. 215-217.
Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species.
Senn L., Entenza J.M., Greub G., Jaton K., Wenger A., Bille J., Calandra T., Prod'hom G., 2006. BMC Infectious Diseases, 6 (9) pp. 1-6.
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2006. Journal of Antimicrobial Chemotherapy, 58 (6) pp. 1208-1214.
 
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis.
Bizzini A., Beggah-Möller S., Moreillon P., Entenza J.M., 2006. FEMS Immunology and Medical Microbiology, 48 (3) pp. 419-423.
New concepts in the pathophysiology of infective endocarditis.
Widmer E., Que Y.A., Entenza J.M., Moreillon P., 2006. Current Infectious Disease Reports, 8 (4) pp. 271-279.
 
Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry.
Saudan C., Entenza J.M., Baume N., Mangin P., Saugy M., 2006. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 844 (1) pp. 168-174.
 
Beta-lactams against methicillin-resistant Staphylococcus aureus.
Guignard B., Entenza J.M., Moreillon P., 2005. Current Opinion in Pharmacology, 5 (5) pp. 479-489.
 
Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains.
Rigoulay C., Entenza J.M., Halpern D., Widmer E., Moreillon P., Poquet I., Gruss A., 2005. Infection and Immunity, 73 (1) pp. 563-572.
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis.
Que Y.A., Haefliger J.A., Piroth L., François P., Widmer E., Entenza J.M., Sinha B., Herrmann M., Francioli P., Vaudaux P. et al., 2005. Journal of Experimental Medicine, 201 (10) pp. 1627-1635. Peer-reviewed.
 
Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis.
Entenza J.M., Moreillon P., Senn M.M., Kormanec J., Dunman P.M., Berger-Bächi B., Projan S., Bischoff M., 2005. Infection and Immunity, 73 (2) pp. 990-998.
 
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats.
Entenza J.M., Loeffler J.M., Grandgirard D., Fischetti V.A., Moreillon P., 2005. Antimicrobial Agents and Chemotherapy, 49 (11) pp. 4789-4792.
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L., Cottagnoud M., Kühn F., Entenza J., Stucki A., Cottagnoud P., 2004. Journal of Antimicrobial Chemotherapy, 53 (2) pp. 305-310.
 
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 2004. Antimicrobial Agents and Chemotherapy, 48 (1) pp. 86-92.
 
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
Vouillamoz J., Entenza J.M., Hohl P., Moreillon P., 2004. Antimicrobial Agents and Chemotherapy, 48 (11) pp. 4322-4327.
 
Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence.
Sanglard D., Ischer F., Marchetti O., Entenza J., Bille J., 2003. Molecular Microbiology, 48 (4) pp. 959-976.
 
Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
Kühn F., Cottagnoud M., Acosta F., Flatz L., Entenza J., Cottagnoud P., 2003. Antimicrobial Agents and Chemotherapy, 47 (8) pp. 2487-2491.
 
Expression of a plant-derived peptide harboring water-cleaning and antimicrobial activities.
Suarez M., Entenza J.M., Doerries C., Meyer E., Bourquin L., Sutherland J., Marison I., Moreillon P., Mermod N., 2003. Biotechnology and Bioengineering, 81 (1) pp. 13-20.
 
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
Marchetti O., Moreillon P., Entenza J.M., Vouillamoz J., Glauser M.P., Bille J., Sanglard D., 2003. Antimicrobial Agents and Chemotherapy, 47 (5) pp. 1565-1570.
 
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.
Cottagnoud P., Cottagnoud M., Acosta F., Flatz L., Kühn F., Stucki A., Entenza J., 2003. European Journal of Clinical Microbiology and Infectious Diseases, 22 (11) pp. 656-662.
 
BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
Entenza J.M., Hohl P., Heinze-Krauss I., Glauser M.P., Moreillon P., 2002. Antimicrobial Agents and Chemotherapy, 46 (1) pp. 171-177.
 
Prophylaxie de l'endocardite infectieuse : apport du modèle expérimental
Moreillon P., Dargère S., Piroth L., Entenza J. M., 2002. Médecine et Maladies Infectieuses, 32 (11) pp. 605-612. Peer-reviewed.
 
Résistance, virulence et fitness de Staphylococcus aureus.
Moreillon P, Entenza JM, 2002. pp. 109-126 dans Infection à l'hôpital: 2ème Journée Maurice Rapin - Aventis. Pneumocoques, staphylocoques actualités, Laboratoires Aventis.
 
Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus
Bischoff M., Entenza J. M., Giachino P., 2001/09. Journal of Bacteriology, 183 (17) pp. 5171-9.
 
Antibiotic resistance: learning from animal feeds and animal experimentation.
Moreillon P., Entenza J.M., 2001. Clinical Microbiology and Infection, 7 (Suppl. 5) pp. 13-18.
 
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza J.M., Que Y.A., Vouillamoz J., Glauser M.P., Moreillon P., 2001. Antimicrobial Agents and Chemotherapy, 45 (11) pp. 3076-3083.
 
Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.
Que Y.A., François P., Haefliger J.A., Entenza J.M., Vaudaux P., Moreillon P., 2001. Infection and Immunity, 69 (10) pp. 6296-6302.
 
Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.
Stutzmann Meier P., Entenza J.M., Vaudaux P., Francioli P., Glauser M.P., Moreillon P., 2001. Infection and Immunity, 69 (2) pp. 657-664.
Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae.
Cottagnoud P., Entenza J.M., Cottagnoud M., Que Y.A., Moreillon P., Taüber M.G., 2001. BMC Microbiology, 1 p. 9.
 
Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus.
Entenza J.M., Foster T.J., Ni Eidhin D., Vaudaux P., Francioli P., Moreillon P., 2000. Infection and Immunity, 68 (9) pp. 5443-5446.
 
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Marchetti O., Entenza J.M., Sanglard D., Bille J., Glauser M.P., Moreillon P., 2000. Antimicrobial Agents and Chemotherapy, 44 (11) pp. 2932-2938.
 
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
Vouillamoz J., Entenza J.M., Féger C., Glauser M.P., Moreillon P., 2000. Antimicrobial Agents and Chemotherapy, 44 (7) pp. 1789-1795.
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Entenza J.M., Caldelari I., Glauser M.P., Moreillon P., 1999. Journal of Antimicrobial Chemotherapy, 44 (6) pp. 775-786.
 
Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1999. Antimicrobial Agents and Chemotherapy, 43 (1) pp. 77-84.
Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence.
Blanc D.S., Petignat C., Moreillon P., Entenza J.M., Eisenring M., Kleiber H., Wenger A., Troillet N., Blanc C., Francioli P., 1999. Clinical Infectious Diseases, 29 (6) pp. 1512-1518.
The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Que Y.A., Entenza J.M., Francioli P., Moreillon P., 1998. Journal of Infectious Diseases, 177 (1) pp. 146-154.
 
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
Entenza J.M., Marchetti O., Glauser M.P., Moreillon P., 1998. Antimicrobial Agents and Chemotherapy, 42 (8) pp. 1889-1894.
Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii.
Entenza J.M., Caldelari I., Glauser M.P., Francioli P., Moreillon P., 1997. Journal of Infectious Diseases, 175 (1) pp. 70-76.
 
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1997. Antimicrobial Agents and Chemotherapy, 41 (8) pp. 1662-1667.
 
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.
Vermot D., Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1996. Antimicrobial Agents and Chemotherapy, 40 (3) pp. 809-811.
 
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.
Moreillon P., Entenza J.M., Francioli P., McDevitt D., Foster T.J., François P., Vaudaux P., 1995. Infection and Immunity, 63 (12) pp. 4738-4743.
 
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
L'Hériteau F., Entenza J.M., Lacassin F., Leport C., Glauser M.P., Moreillon P., 1995. Antimicrobial Agents and Chemotherapy, 39 (7) pp. 1425-1429.
 
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Entenza J.M., Drugeon H., Glauser M.P., Moreillon P., 1995. Antimicrobial Agents and Chemotherapy, 39 (7) pp. 1419-1424.
Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Entenza J.M., Fluckiger U., Glauser M.P., Moreillon P., 1994. Journal of Infectious Diseases, 170 (1) pp. 100-109.
 
Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
Entenza J.M., Blatter M., Glauser M.P., Moreillon P., 1994. Antimicrobial Agents and Chemotherapy, 38 (12) pp. 2683-2688.
 
Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis
Blatter M., Fluckiger U., Entenza J., Glauser M. P., Francioli P., 1993/09. Antimicrobial Agents and Chemotherapy, 37 (9) pp. 1971-6.
 
Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates
Carsenti-Etesse H., Durant J., Entenza J., Mondain V., Pradier C., Bernard E., Dellamonica P., 1993/04. Antimicrobial Agents and Chemotherapy, 37 (4) pp. 921-3.
 
Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence of Staphylococcus aureus and Staphylococcus epidermidis to polystyrene culture plates
Carsenti-Etesse H., Durant J., Bernard E., Mondain V., Entenza J., Dellamonica P., 1992/08. European Journal of Clinical Microbiology and Infectious Diseases, 11 (8) pp. 732-7.
 
Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats
Entenza J. M., Calandra T., Moosmann Y., Malinverni R., Glauser M. P., 1992/06. Antimicrobial Agents and Chemotherapy, 36 (6) pp. 1256-62.
 
[Contribution of bacterial detachment by enzymatic or physical methods to the diagnosis of foreign material infections and chronic osteomyelitis]
Etesse-Carsenti H., Masseyeff M. F., Entenza J., Monnot F., Giaume F., Barbarin A., Rosset M. J., Argenson C., Dellamonica P., 1992/01. Pathologie-Biologie, 40 (1) pp. 40-6.
 
Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice
Carsenti-Etesse H., Entenza J., Durant J., Pradier C., Mondain V., Bernard E., Dellamonica P., 1992. Drugs Under Experimental and Clinical Research, 18 (10) pp. 415-22.
 
[Effect of fibronectin on the adhesion of staphylococci and interaction with pefloxacin's anti-adherence properties]
Etesse-Carsenti H., Entenza J., Mondain V., Durant J., Pradier C., Bernard E., Dellamonica P., 1991/05. Pathologie-Biologie, 39 (5) pp. 414-23.
 
[Adherence properties and production of slime by staphylococci: relation to pathogenicity]
Etesse-Carsenti H., Masseyeff M. F., Entenza J., Bernard E., Dellamonica P., 1990/04. Pathologie-Biologie, 38 (4) pp. 249-54.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University